tetano
Editor, Senior Moderator
Ann N Y Acad Sci. 2019 Oct 28. doi: 10.1111/nyas.14235. [Epub ahead of print] [h=1]Vaccine innovations for emerging infectious diseases-a symposium report.[/h]
Cable J[SUP]1[/SUP], Srikantiah P[SUP]2[/SUP], Crowe JE Jr[SUP]3[/SUP], Pulendran B[SUP]4[/SUP], Hill A[SUP]5[/SUP], Ginsberg A[SUP]6[/SUP], Koff W[SUP]7[/SUP], Mathew A[SUP]8[/SUP], Ng T[SUP]9[/SUP], Jansen K[SUP]10[/SUP], Glenn G[SUP]11[/SUP], Permar S[SUP]12[/SUP], Wilson I[SUP]13[/SUP], Weiner DB[SUP]14[/SUP], Weissman D[SUP]15[/SUP], Rappuoli R[SUP]16[/SUP].
[h=3]Author information[/h] 1 Science Writer, New York, New York. 2 Bill & Melinda Gates Foundation, Seattle, Washington. 3 Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center; and Vanderbilt University, Nashville, Tennessee. 4 Institute for Immunity, Transplantation and Infection; Department of Pathology; and Department of Microbiology & Immunology, Stanford University, Stanford, California. 5 The Jenner Institute, University of Oxford, Oxford, United Kingdom. 6 International AIDS Vaccine Initiative, New York, New York. 7 The Human Vaccines Project, New York, New York. 8 Department of Cell and Molecular Biology, The University of Rhode Island, Kingston, Rhode Island. 9 Department of Microbiology & Immunology, Albert Einstein College of Medicine, New York, New York. 10 Pfizer, New York, New York. 11 Novavax, Rockville, Maryland. 12 Duke University, Durham, North Carolina. 13 Department of Integrative Structural and Computational Biology, The Scripps Research Institute, San Diego, California. 14 Vaccine and Immunotherapy Center, The Wistar Institute, Philadelphia, Pennsylvania. 15 Department of Medicine, The University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania. 16 GlaxoSmithKline, Brentford, United Kingdom.
[h=3]Abstract[/h] Vaccines have been incredibly successful at stemming the morbidity and mortality of infectious diseases worldwide. However, there are still no effective vaccines for many serious and potentially preventable infectious diseases. Advances in vaccine technology, including new delivery methods and adjuvants, as well as progress in systems biology and an increased understanding of the human immune system, hold the potential to address these issues. In addition, maternal immunization has opened an avenue to address infectious diseases in neonates and very young infants. This report summarizes the presentations from a 1-day symposium at the New York Academy of Sciences entitled "Innovative Vaccines against Resistant Infectious Diseases and Emerging Threats," held on May 20, 2019.
? 2019 New York Academy of Sciences.
[h=4]KEYWORDS:[/h] CMV; DNA vaccine; Ebola; HIV; MERS; RNA vaccine; RSV; Zika; antimicrobial resistance; infectious disease; influenza; malaria; maternal immunization; monoclonal antibodies; systems vaccinology; tuberculosis; vaccine; vaccinology
PMID: 31659752 DOI: 10.1111/nyas.14235
Cable J[SUP]1[/SUP], Srikantiah P[SUP]2[/SUP], Crowe JE Jr[SUP]3[/SUP], Pulendran B[SUP]4[/SUP], Hill A[SUP]5[/SUP], Ginsberg A[SUP]6[/SUP], Koff W[SUP]7[/SUP], Mathew A[SUP]8[/SUP], Ng T[SUP]9[/SUP], Jansen K[SUP]10[/SUP], Glenn G[SUP]11[/SUP], Permar S[SUP]12[/SUP], Wilson I[SUP]13[/SUP], Weiner DB[SUP]14[/SUP], Weissman D[SUP]15[/SUP], Rappuoli R[SUP]16[/SUP].
[h=3]Author information[/h] 1 Science Writer, New York, New York. 2 Bill & Melinda Gates Foundation, Seattle, Washington. 3 Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center; and Vanderbilt University, Nashville, Tennessee. 4 Institute for Immunity, Transplantation and Infection; Department of Pathology; and Department of Microbiology & Immunology, Stanford University, Stanford, California. 5 The Jenner Institute, University of Oxford, Oxford, United Kingdom. 6 International AIDS Vaccine Initiative, New York, New York. 7 The Human Vaccines Project, New York, New York. 8 Department of Cell and Molecular Biology, The University of Rhode Island, Kingston, Rhode Island. 9 Department of Microbiology & Immunology, Albert Einstein College of Medicine, New York, New York. 10 Pfizer, New York, New York. 11 Novavax, Rockville, Maryland. 12 Duke University, Durham, North Carolina. 13 Department of Integrative Structural and Computational Biology, The Scripps Research Institute, San Diego, California. 14 Vaccine and Immunotherapy Center, The Wistar Institute, Philadelphia, Pennsylvania. 15 Department of Medicine, The University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania. 16 GlaxoSmithKline, Brentford, United Kingdom.
[h=3]Abstract[/h] Vaccines have been incredibly successful at stemming the morbidity and mortality of infectious diseases worldwide. However, there are still no effective vaccines for many serious and potentially preventable infectious diseases. Advances in vaccine technology, including new delivery methods and adjuvants, as well as progress in systems biology and an increased understanding of the human immune system, hold the potential to address these issues. In addition, maternal immunization has opened an avenue to address infectious diseases in neonates and very young infants. This report summarizes the presentations from a 1-day symposium at the New York Academy of Sciences entitled "Innovative Vaccines against Resistant Infectious Diseases and Emerging Threats," held on May 20, 2019.
? 2019 New York Academy of Sciences.
[h=4]KEYWORDS:[/h] CMV; DNA vaccine; Ebola; HIV; MERS; RNA vaccine; RSV; Zika; antimicrobial resistance; infectious disease; influenza; malaria; maternal immunization; monoclonal antibodies; systems vaccinology; tuberculosis; vaccine; vaccinology
PMID: 31659752 DOI: 10.1111/nyas.14235